Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Hurt

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
The Lancet. Oncology|April 30, 2013
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trialThomas Crosby, Christopher N Hurt, Stephen Falk, et al.
International Journal of Radiation Oncology, Biology, Physics|November 5, 2015
Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic CancerChristopher N Hurt, Somnath Mukherjee, John Bridgewater, et al.
British Journal of Cancer|October 26, 2020
Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancerFrances Willenbrock, Catrin M Cox, Eileen E Parkes, et al.
The Lancet. Oncology|March 12, 2013
Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trialSomnath Mukherjee, Christopher N Hurt, John Bridgewater, et al.
Trials|November 28, 2013
A feasibility study examining the effect on lung cancer diagnosis of offering a chest X-ray to higher-risk patients with chest symptoms: protocol for a randomized controlled trialChristopher N Hurt, Kirsty Roberts, Trevor K Rogers, et al.
BMC Cancer|February 6, 2019
Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)Victoria Y Strauss, Rachel Shaw, Pradeep S Virdee, et al.
British Journal of Cancer|July 24, 2015
Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancerJ Rees, C N Hurt, S Gollins, et al.
British Journal of Cancer|January 11, 2017
Immediate chest X-ray for patients at risk of lung cancer presenting in primary care: randomised controlled feasibility trialRichard D Neal, Allan Barham, Emily Bongard, et al.
BMC Cancer|April 17, 2015
NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinomaSomnath Mukherjee, Christopher N Hurt, Sarah Gwynne, et al.
Trials|August 5, 2018
Patient understanding and acceptability of an early lung cancer diagnosis trial: a qualitative studyHayley C Prout, Allan Barham, Emily Bongard, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
The Lancet. Oncology|April 30, 2013
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trialThomas Crosby, Christopher N Hurt, Stephen Falk, et al.
International Journal of Radiation Oncology, Biology, Physics|November 5, 2015
Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic CancerChristopher N Hurt, Somnath Mukherjee, John Bridgewater, et al.
British Journal of Cancer|October 26, 2020
Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancerFrances Willenbrock, Catrin M Cox, Eileen E Parkes, et al.
The Lancet. Oncology|March 12, 2013
Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trialSomnath Mukherjee, Christopher N Hurt, John Bridgewater, et al.
Trials|November 28, 2013
A feasibility study examining the effect on lung cancer diagnosis of offering a chest X-ray to higher-risk patients with chest symptoms: protocol for a randomized controlled trialChristopher N Hurt, Kirsty Roberts, Trevor K Rogers, et al.
BMC Cancer|February 6, 2019
Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)Victoria Y Strauss, Rachel Shaw, Pradeep S Virdee, et al.
British Journal of Cancer|July 24, 2015
Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancerJ Rees, C N Hurt, S Gollins, et al.
British Journal of Cancer|January 11, 2017
Immediate chest X-ray for patients at risk of lung cancer presenting in primary care: randomised controlled feasibility trialRichard D Neal, Allan Barham, Emily Bongard, et al.
BMC Cancer|April 17, 2015
NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinomaSomnath Mukherjee, Christopher N Hurt, Sarah Gwynne, et al.
Trials|August 5, 2018
Patient understanding and acceptability of an early lung cancer diagnosis trial: a qualitative studyHayley C Prout, Allan Barham, Emily Bongard, et al.
Pageof 5